A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Salagen Indications, Dosage, Storage, Stability - Pilocarpine Hydrochloride
Salagen Indications, Dosage, Storage, Stability - Pilocarpine Hydrochloride
INDICATIONS
SALAGEN® Tablets are indicated for 1) the treatment
of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy
for cancer of the head and neck; and 2) the treatment of symptoms
of dry mouth in patients with Sjögrens syndrome.
DOSAGE AND ADMINISTRATION
Head & Neck Cancer Patients
The recommended initial dose of SALAGEN® Tablets is one
tablet (5 mg) taken three times a day. Dosage should be titrated according
to therapeutic response and tolerance. The usual dosage range is up to
3-6 tablets or 15-30 mg per day. (Not to exceed 2 tablets per dose.) Although
early improvement may be realized, at least 12 weeks of uninterrupted
therapy with SALAGEN® Tablets may be necessary to assess
whether a beneficial response will be achieved. The incidence of the most
common adverse events increases with dose. The lowest dose that is tolerated
and effective should be used for maintenance.
Sjögrens Syndrome Patients
The recommended dose of SALAGEN® Tablets is one tablet
(5 mg) taken four times a day. Efficacy was established by 6 weeks of
use.
HOW SUPPLIED
SALAGEN Tablets, 5 mg, are white, film coated, round tablets, coded MGI
705. Each tablet contains 5 mg pilocarpine hydrochloride.
They are supplied as follows:
NDC 58063-705-10 bottles of 100
Storage: Store at Controlled Room Temperature 15°-30°C
(59°-86°F).
top
